Regulation of utrophin in transgenic mice (multiple letters)

Regulation of utrophin in transgenic mice (multiple letters)

Bibliographic Details
Main Authors:	Davies, K, Stocksley, M, Chakkalakal, J, Bradford, A, Miura, P, De Repentigny, Y, Kothary, R, Jasmin, B
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Regulation of utrophin in transgenic mice.
by: Davies, K
Published: (2005)

Utrophin up-regulation by an artificial transcription factor in transgenic mice
by: Mattei, E, et al.
Published: (2007)

Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.
by: Squire, S, et al.
Published: (2002)

Immunogold confirmation that utrophin is localized to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle.
by: Culle, M, et al.
Published: (2001)

A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
by: Sewry, C, et al.
Published: (2005)

Generation of clusters of dystrophin revertant fibers requires muscle regeneration and tests the function of dystrophin/utrophin transgenes
by: Yokota, T, et al.
Published: (2004)

Confirmation by immunogold labeling that utrophin is localised to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle
by: Cullen, M, et al.
Published: (2001)

Understanding the endothelial function of utrophin.
by: Ehmsen, J, et al.
Published: (2002)

Utrophin luciferase knock-in mouse model for in vivo assessment of drug efficacy in preclinical trials for utrophin upregulation
by: Fairclough, R, et al.
Published: (2010)

Up-regulation of utrophin alleviates the dystrophic phenotype in the mdx mouse heart
by: Sang, E, et al.
Published: (2000)

A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
by: Weir, A, et al.
Published: (2004)

Utrophin upregulation in Duchenne muscular dystrophy.
by: Hirst, R, et al.
Published: (2005)

Oropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida albicans in Mice Expressing the HIV-1 Transgene
by: Louis de Repentigny, et al.
Published: (2015-06-01)

Utrophin in the therapy of Duchenne Muscular Dystrophy
by: Potter, A, et al.
Published: (2006)

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
by: Baban, D, et al.
Published: (2008)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
by: Wakefield, P, et al.
Published: (2000)

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
by: Perkins, K, et al.
Published: (2002)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
by: Perkins, K, et al.
Published: (2018)

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
by: Goyenvalle, A, et al.
Published: (2010)

Heregulin-induced epigenetic regulation of the utrophin-A promoter.
by: Basu, U, et al.
Published: (2007)

The utrophin and dystrophin genes share similarities in genomic structure.
by: Pearce, M, et al.
Published: (1993)

Second-generation compound for the modulation of utrophin in the therapy of DMD
by: Guiraud, S, et al.
Published: (2015)

A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle.
by: Weir, A, et al.
Published: (2002)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
by: Kennedy, T, et al.
Published: (2017)

Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2/mdx mice
by: Kennedy, T, et al.
Published: (2018)

Non-toxic ubiquitous overexpression of utrophin in the mdx mouse.
by: Fisher, R, et al.
Published: (2000)

Identification of serum protein biomarkers for utrophin based DMD therapy.
by: Guiraud, S, et al.
Published: (2017)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019)

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.
by: Goyenvalle, A, et al.
Published: (2010)

Utrophin upregulation in DMD therapy: current status and new tools for the future
by: Fairclough, R, et al.
Published: (2011)

TCR transgenic mice that shed light on immune and environmental regulators in multiple sclerosis.
by: Attfield, K, et al.
Published: (2013)

Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
by: Fisher, R, et al.
Published: (2001)

Ets, Ap-1 and GATA factor families regulate the utrophin B promoter: potential regulatory mechanisms for endothelial-specific expression.
by: Perkins, K, et al.
Published: (2003)

Utrophin in therapy of Duchenne muscular distrophy
by: Fisher, R
Published: (2001)

Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.
by: Nakamura, A, et al.
Published: (2001)

The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.
by: Perkins, K, et al.
Published: (2001)

Novel 5 '-utrophin isoforms exhibit species-specific transcriptional profiles and provide additional candidates for therapeutic up-regulation in DMD
by: Perkins, K, et al.
Published: (2012)

A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.
by: Cole, M, et al.
Published: (2002)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
by: Griffin, J, et al.
Published: (2002)

Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
by: Fairclough, R, et al.
Published: (2012)